decentralised clinical trials

News

US govt taps Walgreens for decentralised trials

Retail pharmacy giant Walgreens has signed a five-year contract with the US government – worth up to $100 million – for access to its decentralised clinical trials (DCT) network.

Patients

FDA wants to make the home a healthcare hub

During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs.

News

Boehringer will use Walgreens trials unit for obesity trial

Walgreens’ plans to disrupt the clinical trials sector have taken a step forward with a high-profile partnership with Boehringer Ingelheim.

R&D

Embracing new delivery models in the UK

The clinical research landscape in the UK is on the cusp of a major transformation.

Patients

Accelerating inclusion in innovation: Gender diversity in cl...

Clinical research continues to struggle with a lack of representation within trial populations, and gender diversity in clinical trials remains a critical issue.

R&D